Mission Creek Capital Partners, Inc. Amgen Inc Transaction History

Mission Creek Capital Partners, Inc.

$421 Million
Q3 2024

A detailed history of Mission Creek Capital Partners, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 9,545 shares of AMGN stock, worth $2.67 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

9,545

Previous 9,517 0.29%

Holding current value

$2.67 Million

Previous $2.97 Million 3.43%

% of portfolio

0.73%

Previous 0.75%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $8,662 - $9,446	28 Added 0.29%	9,545 $3.08 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $28,114 - $34,166	107 Added 1.14%	9,517 $2.97 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $189,553 - $228,814	-705 Reduced 6.97%	9,410 $2.68 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $56,509 - $63,749	221 Added 2.23%	10,115 $2.91 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $27,768 - $34,475	-127 Reduced 1.27%	9,894 $2.66 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $153,203 - $181,159	715 Added 7.68%	10,021 $2.22 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $44,932 - $54,764	199 Added 2.19%	9,306 $2.25 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $48,096 - $61,112	-210 Reduced 2.25%	9,107 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $21,772 - $24,555	97 Added 1.05%	9,317 $2.1 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $24,916 - $27,727	-108 Reduced 1.16%	9,220 $2.24 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $9,209 - $10,187	42 Added 0.45%	9,328 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $6,165 - $7,055	31 Added 0.33%	9,286 $2.09 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $11,038 - $12,932	52 Added 0.57%	9,255 $1.97 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $32,000 - $35,502	137 Added 1.51%	9,203 $2.24 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $27,738 - $32,325	-125 Reduced 1.36%	9,066 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $128,746 - $153,313	595 Added 6.92%	9,191 $2.11 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $225,967 - $251,294	963 Added 12.62%	8,596 $2.19 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $2,373 - $2,912	12 Added 0.16%	7,633 $1.8 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $46,835 - $62,116	-257 Reduced 3.26%	7,621 $1.55 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.49 Million - $1.92 Million	7,878 New	7,878 $1.9 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.

Account

Mission Creek Capital Partners, Inc. Amgen Inc Transaction History